Ohio Administrative Code Search
Rule |
---|
Rule 3701:1-58-17 | Suppliers for sealed sources or devices for medical use.
... with a license issued under Chapter 3701:1-40 and rules 3701:1-38-02 and 3701:1-46-44 of the Administrative Code or equivalent requirements of the United States nuclear regulatory commission or an agreement state; (B) Sealed sources or devices noncommercially transferred from an individual licensed in accordance with rule 3701:1-58-06 of the Administrative Code or a United States nuclear regulatory commission or ag... |
Rule 3701:1-58-19 | Training for an authorized medical physicist.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require the authorized medical physicist to be an individual who: (A) Is certified by a specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement state and who meets the requirements in paragraphs (B)(2) and (C) of this rule. The names of board cer... |
Rule 3701:1-58-19 | Training for an authorized medical physicist.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require the authorized medical physicist to be an individual who: (A) Is certified by a specialty board whose certification process has been recognized by the director, the United States nuclear regulatory commission, or an agreement state and who meets the requirements in paragraph (C) of this rule. The names of b... |
Rule 3701:1-58-22 | Recentness of training.
...ng and experience specified in rules 3701:1-58-12 to 3701:1-58-21, 3701:1-58-32 to 3701:1-58-71, and 3701:1-58-104 of the Administrative Code must have been obtained within the seven years preceding the date of application or the individual must have had related continuing education and experience since the required training and experience was completed. |
Rule 3701:1-58-23 | Possession, use, and calibration of instruments used to measure the activity of unsealed radioactive material.
...ts performed in accordance with rule 3701:1-58-25 of the Administrative Code, a licensee shall possess and use instrumentation to measure the activity of unsealed radioactive material before it is administered to each patient or human research subject. (B) A licensee shall calibrate the instrumentation required in paragraph (A) of this rule in accordance with nationally recognized standards or the manufacturer's ins... |
Rule 3701:1-58-24 | Calibration of survey instruments.
...liance with this chapter and Chapter 3701:1-38 of the Administrative Code before first use, annually, and following a repair that affects the calibration. A licensee shall: (1) Calibrate all scales with readings up to ten millisievert (one thousand millirem) per hour with a radiation source; (2) Calibrate two separate readings on each scale or decade that will be used to show compliance; and (3) Conspicuously not... |
Rule 3701:1-58-25 | Determination of dosages of unsealed radioactive material for medical use.
..., this determination must be made by: (1) Direct measurement of radioactivity; or (2) A decay correction, based on the activity or activity concentration determined by: (a) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission, or agreement state requirements; (b) An United States nuclear regulatory commission, or agreement... |
Rule 3701:1-58-26 | Authorization for calibration, transmission, and reference sources.
...Any person authorized by rule 3701:1-58-06 of the Administrative Code for medical use of radioactive material may receive, possess, and use any of the following radioactive material for check, calibration, transmission, and reference use: (A) Sealed sources, not exceeding 1.11 gigabecquerels (thirty millicuries) each, manufactured and distributed by a person licensed under rule 3701:1-46-44 of the Administrative Cod... |
Rule 3701:1-58-26 | Authorization for calibration, transmission, and reference sources.
...A) Any person authorized by rule 3701:1-58-06 of the Administrative Code for medical use of radioactive material may receive, possess, and use any of the following radioactive material for check, calibration, transmission, and reference use: (1) Sealed sources, not exceeding 1.11 gigabecquerels (thirty millicuries) each, manufactured and distributed by a person licensed under rule 3701:1-46-44 of... |
Rule 3701:1-58-26 | Authorization for calibration, transmission, and reference sources.
...(A) Any person authorized by rule 3701:1-58-06 of the Administrative Code for medical use of radioactive material may receive, possess, and use any of the following radioactive material for check, calibration, transmission, and reference use: (1) Sealed sources, not exceeding 1.11 gigabecquerels (thirty millicuries) each, manufactured and distributed by a person licensed under rule 3701:1-46-44 o... |
Rule 3701:1-58-27 | Requirements for possession of sealed sources and brachytherapy sources.
... possession of a sealed source shall: (1) Test the source for leakage before its first use unless the licensee has a certificate from the supplier indicating that the source was tested within six months before transfer to the licensee; and (2) Test the source for leakage at intervals not to exceed six months or at other intervals approved by the director, United States nuclear regulatory commission, or an agreemen... |
Rule 3701:1-58-29 | Surveys of ambient radiation exposure rate.
...n to the surveys required by Chapter 3701:1-38 of the Administrative Code, a licensee shall survey, with a radiation detection survey instrument at the end of each day of use, the following: (1) All areas where unsealed radioactive material requiring a written directive was prepared for use or administered. This includes all unsealed radiopharmaceuticals prepared for use or administered under rule 3701:1-58-37 of t... |
Rule 3701:1-58-30 | Release of individuals containing unsealed radioactive material or implants containing radioactive material.
...is likely to exceed one millisievert (0.1 rem). If the total effective dose equivalent to a nursing infant or child could exceed one millisievert (0.1 rem) assuming there were no interruption of breast-feeding, the instructions must also include: (1) Guidance on the interruption or discontinuation of breast-feeding; and (2) Information on the potential consequences, if any, of failure to follow the guidance. (C) ... |
Rule 3701:1-58-30 | Release of individuals containing unsealed radioactive material or implants containing radioactive material.
...ikely to exceed one millisievert (0.1 rem). If the total effective dose equivalent to a nursing infant or child could exceed one millisievert (0.1 rem) assuming there were no interruption of breast-feeding, the instructions must also include: (1) Guidance on the interruption or discontinuation of breast-feeding; and (2) Information on the potential consequences, if any, of failure to follow the ... |
Rule 3701:1-58-31 | Provision of mobile medical service.
...oviding mobile medical service shall: (1) Obtain a letter signed by the management of each client for which services are rendered that permits the use of radioactive material at the client's address and clearly delineates the authority and responsibility of the licensee and the client; (2) Check instruments used to measure the activity of unsealed radioactive material for proper function before medical use at each ... |
Rule 3701:1-58-32 | Use of unsealed radioactive material for uptake, dilution, and excretion studies for which a written directive is not required.
...irective under paragraph (B) of rule 3701:1-58-15 of the Administrative Code, a licensee may use any unsealed radioactive material prepared for medical use for uptake, dilution, or excretion studies that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state requirements; or (2) A... |
Rule 3701:1-58-33 | Training for uptake, dilution, and excretion studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-32 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement s... |
Rule 3701:1-58-33 | Training for uptake, dilution, and excretion studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-32 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or a... |
Rule 3701:1-58-34 | Use of unsealed radioactive material for imaging and localization studies for which a written directive is not required.
...irective under paragraph (B) of rule 3701:1-58-15 of the Administrative Code, a licensee may use any unsealed radioactive material prepared for medical use for imaging and localization studies that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state requirements; or (2) A PET ... |
Rule 3701:1-58-35 | Permissible molybdenum-99, strontium-82, and strontium-85 concentrations.
... a radiopharmaceutical that contains: (1) More than 0.15 kilobecquerel of molybdenum-99 per megabecquerel of technetium-99m (0.15 microcurie of molybdenum-99 per millicurie of technetium-99m); or (2) More than 0.02 kilobecquerel of strontium-82 per megabecquerel of rubidium-82 chloride injection (0.02 microcurie of strontium-82 per millicurie of rubidium-82 chloride); or more than 0.2 kilobecquerel of strontium-85 ... |
Rule 3701:1-58-35 | Permissible molybdenum-99, strontium-82, and strontium-85 concentrations.
... a radiopharmaceutical that contains: (1) More than 0.15 kilobecquerel of molybdenum-99 per megabecquerel of technetium-99m (0.15 microcurie of molybdenum-99 per millicurie of technetium-99m); or (2) More than 0.02 kilobecquerel of strontium-82 per megabecquerel of rubidium-82 chloride injection (0.02 microcurie of strontium-82 per millicurie of rubidium-82 chloride); or more than 0.2 kilobecque... |
Rule 3701:1-58-36 | Training for imaging and localization studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized in rule 3701:1-58-34 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement state... |
Rule 3701:1-58-36 | Training for imaging and localization studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized in rule 3701:1-58-34 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an a... |
Rule 3701:1-58-37 | Use of unsealed radioactive material for which a written directive is required.
...required that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state requirements; or (2) A PET radioactive drug producer licensed in accordance with paragraph (I) of rule 3701:1-40-14 of the Administrative Code or equivalent United States nuclear regulatory commission or agreeme... |
Rule 3701:1-58-37 | Use of unsealed radioactive material for which a written directive is required.
... material identified in paragraph (B)(1)(b)(vi) of rule 3701:1-58-40 the Administrative Code prepared for medical use and for which a written directive is required that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state requirements; or (2) A PET radioactive ... |